Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients (MelaViD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by European Institute of Oncology
Information provided by (Responsible Party):
European Institute of Oncology Identifier:
First received: December 21, 2010
Last updated: August 9, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2025
  Estimated Primary Completion Date: February 2025 (Final data collection date for primary outcome measure)